Are Adverse Pregnancy Outcomes Associated With Accelerated Cardiovascular Events in SLE?
Placental-related secretions leading to vascular insufficiency and hypoxia are thought to play a role in the speculated elevated risk for CV events in pregnant women with SLE.
- Hendawy SF, Abdel-Mohsen D, Ebrahim SE, et al. Pregnancy-related complications in patients with systemic lupus erythematosus, an Egyptian experience. Clin Med Insights Reprod Health. 2011;5:17-24.
- Soh MC, Nelson-Piercy C, Westgren M, McCowan L, Pasupathy D. Do adverse pregnancy outcomes contribute to accelerated cardiovascular events seen in young women with systemic lupus erythematosus? Lupus. 2017;26(13):1351-1367.
- Yurkovich M, Vostretsova K, Chen W, et al. Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care Res (Hoboken). 2013;66(4):608-616.
- Simard JF, Rossides M, Arkema EV, et al. Preeclampsia and incident cardiovascular disease in SLE pregnancy. Arthritis Rheumatol. 2017;69(suppl 10):1812.
- Cain MA, Salemi JL, Tanner JP, Kirby RS, Salihu HM, Louis JM. Pregnancy as a window to future health: maternal placental syndromes and short-term cardiovascular outcomes. Am J Obstet Gynecol. 2016;215(4):484.e1-484.e14.
- Soh MC, Nelson-Piercy C, Dib F, Westgren M, McCowan L, Pasupathy D. Brief report: association between pregnancy outcomes and death from cardiovascular causes in parous women with systemic lupus erythematosus: a study using Swedish population registries. Arthritis Rheumatol. 2015;67(9):2376-2382.
- Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335(7627):974.
- Lin P, Rhew E, Ness RB, et al. Adverse pregnancy outcomes and subsequent risk of cardiovascular disease in women with systemic lupus erythematosus. Lupus Sci Med. 2014;1:e000024.
- Kim MY, Buyon JP, Guerra MM, et al. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study. Am J Obstet Gynecol. 2016;214(1):108.e1-08.e14.